AKEBIA THERAPEUTICS INC (AKBA)
US00972D1054 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to AKBA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.1. This target is 272.26% above the current price.
AKBA was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about AKBA.
In the previous month the buy percentage consensus was at a similar level.
AKBA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-17 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-09-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-28 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2023-08-11 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2023-06-21 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2023-06-14 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2023-06-02 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2023-05-31 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2023-05-30 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2023-05-26 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2023-05-09 | Needham | Reiterate | Neutral |
| 2023-04-26 | HC Wainwright & Co. | Maintains | Neutral |
| 2023-03-31 | HC Wainwright & Co. | Reiterate | Neutral |
| 2023-03-10 | HC Wainwright & Co. | Reiterate | Neutral |
| 2023-02-22 | HC Wainwright & Co. | Maintains | Neutral |
| 2022-05-16 | HC Wainwright & Co. | Maintains | Neutral |
| 2021-11-11 | HC Wainwright & Co. | Maintains | Buy |
| 2021-03-08 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-03-08 | HC Wainwright & Co. | Maintains | Buy |